Brief: TELA Bio Q1 Revenue USD 16.603 Million Vs. IBES Estimate USD 16.3 Million
09/05/2024 21:05
May 09 (Reuters) - TELA Bio Q1 gross profit USD 11.336 million. * Q1 basic EPS USD -0.23 * Q1 operating expenses USD 23.742 million * Q1 income from operations USD -4.826 million * Q1 net income USD -5.661 million * outlook FY revenue USD 74.5-76.5 million
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview